-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Chemours, Lowers Price Target to $16

Benzinga·04/01/2025 14:11:23
Listen to the news
Barclays analyst Michael Leithead maintains Chemours (NYSE:CC) with a Equal-Weight and lowers the price target from $19 to $16.